Anti-aging: state of the art

Published on LessWrong, this is one of the more approachable summaries of the field. One exciting point: “Today, there are over 130 longevity biotechnology companies and over 50 anti-aging drugs in clinical trials in humans.” However, a commenter offers this alternative interpretation: “The fact that there are 130 companies working on the problem with only minor laboratory success in the last decade indicates that the marginal returns to new inputs is low.” learn more

Leave a Reply

Your email address will not be published. Required fields are marked *